Health Care Organizations on Concerns & Exemptions Regarding Tariffs
Tariffs on medical goods threaten healthcare costs, access, and supply chains. Leading health groups urge exemptions to safeguard patient care.
Government & Legislative Affairs
Learn more about our Advocacy work.
AdvaMed® 2025 State Policy Briefing: PFAS
Hear from expert speakers as they give an overview of PFAS and emerging PFAS policy trends across the country.
Make America Healthy Again Fact Sheet
An overview of the Make America Healthy Again Commission, its mission to address chronic disease in the U.S., and policy initiatives aimed at improving public health.
Reciprocal Tariffs Fact Sheet
A breakdown of the administration’s trade policy, highlighting key areas where the U.S. seeks to level the playing field with trading partners through reciprocal tariffs.
2025 Reciprocal Tariffs and Trade
A policy memorandum outlining the administration’s strategy for fair and reciprocal trade, addressing tariff imbalances and protecting American industries.
AdvaMed® 2025 State Policy Briefing: Data Privacy
Hear from AdvaMed®’s data privacy expert, Terry Chang, on the critical exemptions in state data privacy laws across the country.
AdvaMed® Tariff Talking Points
Essential advocacy insights on how new tariffs impact the MedTech industry. Use these key messages when engaging with policymakers, industry stakeholders, and media.
FAQs: President Trump’s Tariffs on Mexico, Canada, and China
Get clear answers on the scope, impact, and implementation of tariffs on key U.S. trade partners. These FAQs explains tariff rates, exemptions, economic implications, and potential retaliatory actions.
Key Congressional Dates
A timeline of critical policy and legislative deadlines, including budget resolutions, trade discussions, and key votes that may impact MedTech and global trade policies.
AdvaMed® 2025 State Policy Briefing: AI in Healthcare
AdvaMed®’s digital health policy expert, Geeta Pamidimukkala, and payment and health care delivery policy expert, Kirsten Tullia, break down how AI/ML technologies are transforming patient care and the FDA’s policy.